Tim Sparwasser Selected Research

Autoantigens

4/2012	Regulatory T cells selectively preserve immune privilege of self-antigens during viral central nervous system infection.
7/2011	Regulatory T cells control the Th1 immune response in murine crescentic glomerulonephritis.
10/2010	Selective depletion of Foxp3+ regulatory T cells improves effective therapeutic vaccination against established melanoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Tim Sparwasser Research Topics

Disease

34	Infections 01/2023 - 05/2008
26	Inflammation (Inflammations) 10/2023 - 08/2010
17	Neoplasms (Cancer) 01/2019 - 06/2008
7	Autoimmune Diseases (Autoimmune Disease) 12/2021 - 01/2007
6	Hypersensitivity (Allergy) 12/2020 - 01/2012
5	Colitis 11/2023 - 07/2009
5	Virus Diseases (Viral Diseases) 01/2013 - 02/2011
4	Melanoma (Melanoma, Malignant) 08/2015 - 01/2010
3	Psoriasis (Pustulosis Palmaris et Plantaris) 10/2023 - 07/2012
3	Tuberculosis (Tuberculoses) 01/2021 - 05/2008
3	Lymphoma (Lymphomas) 01/2019 - 05/2009
3	Colonic Neoplasms (Colon Cancer) 01/2018 - 04/2011
3	Asthma (Bronchial Asthma) 01/2018 - 10/2016
3	Pneumonia (Pneumonitis) 10/2015 - 10/2011
3	Persistent Infection 01/2013 - 01/2012
2	Bites and Stings (Sting) 11/2023 - 01/2022
2	Necrosis 01/2023 - 05/2011
2	Pneumococcal Infections 01/2021 - 01/2020
2	Fibrosis (Cirrhosis) 01/2020 - 12/2011
2	Porcine Reproductive and Respiratory Syndrome (PRRS) 01/2017 - 01/2015
2	Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental) 03/2016 - 05/2011
2	Graft vs Host Disease (Graft-Versus-Host Disease) 01/2016 - 09/2015
2	Eosinophilia 12/2014 - 12/2012
2	Disease Progression 09/2014 - 07/2012
2	Neoplasm Metastasis (Metastasis) 04/2014 - 04/2011
2	Anaphylaxis (Anaphylactic Shock) 01/2013 - 02/2006
2	Contact Dermatitis (Eczema, Contact) 12/2012 - 05/2012
1	Hepatitis 11/2023
1	Protozoan Infections 01/2023
1	Reinfection 01/2021
1	Hyperglycemia 01/2021
1	Hypertriglyceridemia 01/2020

Drug/Important Bio-Agent (IBA)

20	CytokinesIBA 10/2023 - 02/2011
10	AntigensIBA 01/2019 - 04/2011
9	Interleukin-10 (Interleukin 10)IBA 01/2022 - 05/2008
8	Proteins (Proteins, Gene)FDA Link 10/2023 - 02/2006
7	AllergensIBA 12/2020 - 08/2010
6	Diphtheria ToxinIBA 01/2020 - 12/2009
6	VaccinesIBA 01/2018 - 06/2008
6	Antiviral Agents (Antivirals)IBA 01/2013 - 08/2009
6	OvalbuminIBA 01/2013 - 02/2010
5	Toll-Like Receptors (Toll-Like Receptor)IBA 01/2020 - 05/2011
4	Anti-Bacterial Agents (Antibiotics)IBA 10/2023 - 01/2020
4	AntibodiesIBA 01/2023 - 10/2013
4	InterferonsIBA 01/2022 - 01/2013
4	Heparin-binding EGF-like Growth Factor (HB-EGF)IBA 01/2018 - 11/2009
4	Immunoglobulin E (IgE)IBA 12/2014 - 02/2006
3	Interleukin-17 (Interleukin 17)IBA 10/2023 - 01/2018
3	Acetyl-CoA CarboxylaseIBA 01/2023 - 01/2016
3	RNA (Ribonucleic Acid)IBA 01/2023 - 01/2010
3	EnzymesIBA 01/2023 - 01/2016
3	Fatty Acids (Saturated Fatty Acids)IBA 01/2023 - 01/2016
3	T-Cell Antigen Receptors (T-Cell Receptor)IBA 01/2021 - 02/2010
3	Interleukin-2 (IL2)IBA 01/2020 - 05/2010
3	Peptides (Polypeptides)IBA 01/2019 - 07/2011
3	ChemokinesIBA 01/2018 - 12/2013
3	AutoantibodiesIBA 01/2017 - 05/2011
3	Granzymes (Granzyme)IBA 08/2014 - 06/2012
3	AutoantigensIBA 04/2012 - 10/2010
2	Linezolid (Zyvox)FDA Link 10/2023 - 12/2021
2	Membrane Proteins (Integral Membrane Proteins)IBA 01/2023 - 01/2018
2	soraphen AIBA 01/2021 - 11/2014
2	Interleukin-4 (Interleukin 4)IBA 01/2018 - 01/2013
2	Interleukin-12 (IL 12)IBA 01/2018 - 12/2010
2	Immunoglobulin G (IgG)IBA 01/2018 - 06/2017
2	Messenger RNA (mRNA)IBA 01/2018 - 06/2015
2	LigandsIBA 01/2018 - 05/2011
2	Antimicrobial PeptidesIBA 05/2017 - 01/2012
2	Pattern Recognition ReceptorsIBA 01/2017 - 01/2015
2	Interleukin-9 (Interleukin 9)IBA 02/2014 - 10/2011
2	DC-specific ICAM-3 grabbing nonintegrin (DC-SIGN)IBA 10/2013 - 05/2008
2	Interleukin-7 (Interleukin 7)IBA 02/2011 - 05/2009
2	Forkhead Transcription Factors (Forkhead Box Proteins)IBA 06/2010 - 01/2007
1	OxazoloneIBA 11/2023
1	Concanavalin AIBA 11/2023
1	Imiquimod (Aldara)FDA LinkGeneric 10/2023
1	Electron Transport Complex IV (Cytochrome c Oxidase)IBA 10/2023
1	CalciumIBA 01/2023
1	Surface Antigens (Surface Antigen)IBA 01/2023
1	Interferon Type IIBA 01/2022
1	Aryl Hydrocarbon Receptors (Aryl Hydrocarbon Receptor)IBA 01/2022
1	DNA (Deoxyribonucleic Acid)IBA 01/2022
1	Heme (Haem)IBA 01/2021
1	Interleukin-22 (IL-22)IBA 01/2021
1	cytochrome P-450 CYP121IBA 01/2021
1	MacrolidesIBA 01/2021
1	SpermidineIBA 01/2021
1	Clarithromycin (Biaxin)FDA LinkGeneric 01/2021
1	CollagenIBA 01/2020
1	Sterol Regulatory Element Binding Protein 1IBA 01/2020
1	Toll-Like Receptor 9IBA 01/2020
1	OligodeoxyribonucleotidesIBA 01/2020
1	LipidsIBA 01/2020
1	CPG-oligonucleotideIBA 01/2020
1	Erythropoietin FDA Link 01/2020
1	sodium sulfate (sodium bisulfate)FDA LinkGeneric 12/2019

Therapy/Procedure

11	Therapeutics 01/2019 - 12/2010
10	Immunotherapy 11/2023 - 05/2009
3	Ligation 01/2020 - 01/2013
1	Immunomodulation 01/2021